Intramedullary Hip Screws for Intertrochanteric Fractures

Recovery from hip screw surgery varies according to the fracture, the patient’s overall health, bone quality, surgical approach, and rehabilitation plan. This manufacturing page does not provide clinical recovery guidance. Patients should follow the treating surgeon’s instructions regarding weight-bearing, physical therapy, wound care, and follow-up appointments, since the surgical team is best positioned to discuss individual recovery expectations.

The service life of a hip screw depends on the patient’s healing, bone quality, implant design, positioning, activity, and clinical circumstances. A treating orthopedic surgeon can explain how long a specific implant is expected to remain in place and whether removal may ever be considered. MoManTech supports manufacturing for highly engineered trauma components but does not provide patient-specific medical advice.

The timeline for walking normally after hip screw surgery differs between patients and depends on fracture healing, stability, weight-bearing restrictions, pain, strength, balance, and rehabilitation progress. The surgeon and physical therapy team determine when walking aids or increased activity are appropriate. Patients should not change weight-bearing status without guidance from their clinical care team.

MoManTech supports intramedullary hip screw programs with design-for-manufacturability consultation, precision CNC milling and turning, multi-axis Swiss work, wire EDM, additive prototyping, finishing, laser marking, inspection, and documented quality processes. These capabilities can support development, prototyping, first articles, and production of highly engineered trauma components and related orthopedic instrumentation.

Yes. MoManTech supports prototype development, first articles, low-volume production, and larger production runs for orthopedic medical-device components. The service catalog identifies prototype quantities from 1–10 units and production runs of 100+ for selected capabilities. The appropriate process and quantity depend on the design, documentation, inspection requirements, and manufacturing plan.

Material selection depends on the approved device design, intended application, specifications, and customer requirements. MoManTech’s listed capabilities include 17-4 stainless steel, 316L stainless steel, titanium beta options, plastics, and composite reinforcements for additive prototyping. Material suitability and production use should be confirmed during engineering review and design-for-manufacturability consultation.

The service catalog states that MoManTech supports FDA-regulated processes and provides ISO 13485:2016 compliance documentation. Its capabilities include controlled machining, finishing, marking, comprehensive inspection, and documented quality support. Specific regulatory deliverables, device documentation, and customer responsibilities should be reviewed during project planning for the particular intramedullary hip screw program.

An OEM can begin by sharing the current design, drawings or models, specifications, expected quantities, inspection requirements, and development goals. MoManTech can then apply design-for-manufacturability expertise to review the component and identify suitable machining, EDM, prototyping, finishing, marking, and quality-control approaches. This supports a clear path from concept planning through production discussion.